HPLC and chemical determination of caffeine content in selected tea samples sourced from supermarkets in Sagamu, Nigeria

Main Article Content

Olufunmilayo E. Adejumo
Temitope D. Ogbonyenitan
Olatunde A. Ayodele

Abstract

Background: There are reports of abuse and toxicity resulting from taking caffeine, a psychoactive stimulant derived from various products like tea, which is known to increase alertness and elevate mood but prone to addiction.


Objectives: This study was aimed at determination of the caffeine content of green, herbal, and black tea samples sourced from supermarkets in Sagamu, south-west Nigeria by chemical and HPLC technique.


Methods: Chemical analysis was by precipitation, filtration followed by organic solvent extraction while the HPLC is equipped with a reverse phase C18 column, detection wavelength of 272 nm and run with a mobile phase of water: methanol (30:70% v/v).


Results: Caffeine eluted at about 1.58 mins to 1.65 mins. The calibration graph for the HPLC method was linear within the range of 10-100 µg/ml (R² = 0.9997) with the regression equation of y=73.88x-25.96. Percentage (%) caffeine by chemical analysis ranged from 0.13±0.01 to 1.72±0.13; and by h.p.l.c from 0.14±0.192 to 0.85±0.025 while caffeine content was below detection limit in two samples, (D, and I); where sample D had the lowest caffeine content by chemical method but undetectable by the h.p.l.c method. However, sample F had 0.66±0.20 by the chemical method but gave the lowest caffeine content of 0.14±0.192 by the h.p.l.c method. There was statistically significant difference between the mean results of the two methods (t=4.931, p < 0.05).


Conclusion: All tea samples contained caffeine in amounts that are low and safe, and that meets with regulatory specifications such as the US FDA. This has positive implications for public health and quality control of the tea samples.

Downloads

Download data is not yet available.

Article Details

How to Cite
Adejumo, O. E., Ogbonyenitan, T. D., & Ayodele, O. A. (2023). HPLC and chemical determination of caffeine content in selected tea samples sourced from supermarkets in Sagamu, Nigeria. West African Journal of Pharmacy, 33(1), 99-113. https://doi.org/10.60787/wapcp-33-1-266
Section
Articles
Author Biography

Olatunde A. Ayodele, Department of Pharmaceutical and Medicinal Chemistry, Olabisi Onabanjo University, Sagamu, Nigeria

 

 

References

McKay DL, Blumberg JB (2002). The role of tea in human health: an update. Journal of American College Nutrition 21: 1-13.

Gardner EJ, Ruxton CH, Leeds AR (2007). Black teahelpful or harmful? A review of the evidence. European Journal of Clinical Nutrition 61(1): 3-18.

Chung FL, Schwartz J, Herzog CR, Yang YM (2003). Journal of Nutrition 133(10): 3268S-74S.

Butt MS, Sultan MT (2009). Green tea: Nature's defense against malignancies. Critical Review of Food Science and Nutrition 49(5): 463-473.

Stangl V, Dreger H, Stangl K editors. (2007). Molecular targets of tea polyphenols in the cardiovascular system. Cardiovascular Research

(2): 348-58.

Babu PV, Sabitha KE, Shyamaladevi CS (2006). Therapeutic effect of green tea extract on oxidative stress in aorta and heart of streptozotocin diabetic rats. Chemico-Biological Interactions 162: 114.

Babu PV, Liu D (2008). Green tea catechins and cardiovascular health: An update. Current Medicinal Chemistry 15(18): 1840-1850.

Varnam AH, Sutherland JP (1994). "Beverages: Technology, Chemistry and Microbiology." London: Chapman &Hall.

Graham HN (1992). Green tea composition, consumption, and polyphenol chemistry. Preventive Medicine 21: 334-350.

Lampe JW (2003). Spicing up a vegetarian diet: Chemopreventive effects of phytochemicals. American Journal of Clinical Nutrition 78: 579S-83S.

Frankel EN, Finley JW (2008). How to standardize the multiplicity of methods to evaluate natural antioxidants. Journal of Agricultural Food Chemistry 56(13): 4901-4908.

Khan N, Afaq F, Saleem M, Ahmad N, Mukhtar H (2006). Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate. Cancer Research 66(5): 2500-2505.

Tan LC, Koh WP, Yuan JM, Wang R, Au W-L, Tan JH, Tan E-K, Yu MC (2008). Differential effects of black versus green tea on risk of Parkinson's disease in the Singapore Chinese Health Study. American Journal of Epidemiology 167: 553-560.

Finger A, Kuhr S, Engelhardt UH (1992). Chromatography of tea constituents. Journal of Chromatography 624: 293-315.

Balentine DA, Wiseman SA, Bouwens LCM (1997). The chemistry of tea flavonoids. Critical Reviews in Food Science and Nutrition 37: 693-704.

Wang J, Sporns P (2000). MALDI-TOF analysis of food flavonols glycoside. Journal of Agricultural and Food Chemistry 48: 1657-1662.

Del Rio D, Stewart AJ, Mullen W, Burns J, Lean MEJ, Brighenti F, Crozier A (2004). HPLC-MSn analysis of phenolic compounds and purine alkaloids in green and black tea. Journal of Agricultural and Food Chemistry 52: 2807-2815.

Del Rio D, Calani L, Cordero C, Salvatore S, Pellegrini N, Brighenti F (2010). Bioavailability and catabolism of green tea flavan-3-ols in humans. Nutrition 26(11-12): 1110-1116.

Crozier A, Jaganath IB, Clifford MN (2009). Dietary phenolics: Chemistry, bioavailability, and effects on health. Natural Products Reports 26(8): 1001-1043.

Mukhtar H, Wang ZY, Katlya SK, Agarwal R (1992). Tea components: antimutagenic and anticarcinogenic effects. Preventive Medicine 21: 351-360.

Lovett R (2005). "Coffee: The demon drink?". New Scientist (2518).

Verma R, Kumar L (2010). Characterization of Caffeine Isolated from Camellia Sinensis Leaves of Sikkim Himalayan Region. Journal of Chemical and Pharmaceutical Research 2(4): 194-198

Chen ZP, Schell JB, Ho CT, Chen KY (1998). Green Tea epigallocatechin gallate shows a pronounced growth inhibitory effect on cancerous cells but not on their normal counterparts. Cancer Letters 129: 173-179.

Ahmad N, Gupta S, Mukhtar H (2000). Green tea epigallocatechin-3-gallate differentially modulates nuclear factor -B in cancer cells versus normal cells. Archives of Biochemistry and Biophysics 376: 338-346

Busto U, Bendayan R, Sellers EM (1989). Clinical pharmacokinetics of non-opiate abuse drugs. Clinical Pharmacokinetics 16: 1-26.

Brachtel D, Richter E (1992). Absolute bioavailability of caffeine from tablet formulation. Journal of Hepatology 16: 385.

Aurnaud MJ (1987). The pharmacology of caffeine. Progress in Drug Research 31: 273.

Goth R, Cleaver JT (1976). Metabolism of caffeine to nucleic acid precursors in mammalian cells. Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis 36(1): 105-113

Suzuki T, Pervin M, Goto S, Isemura M, Nakamura Y (2016). Beneficial effects of tea and the green tea catechin epigallocatechin-3-gallate on obesity. Molecules 21(10): 1305

Klang MJ, Wang N, Meoni LA (2002). Coffee intake and Risk of Hypertension: The John Hopkins Precursors Study. Archives of Internal Medicine 162: 657-662

Conde SV, da Silva TN, Gonzalez C, Carmo MM, Monteiro EC, Guarino MP (2012). Chronic caffeine intake decreases circulating catecholamines and prevents diet-induced insulin resistance and hypertension in rats. British Journal of Nutrition 107:86-95

Guarino MP, Ribeiro MJ, Sacramento JF, Conde SV (2013). Chronic caffeine intake reverses age-induced insulin resistance in the rat: effect on skeletal muscle Glut4 transporters and AMPK activity. Age (Dordr) 5: 1755-1765

Panchal SK, Wong WY, Kauter K, Ward LC, Brown L (2012). Caffeine attenuates metabolic syndrome in diet-induced obese rats. Nutrition 28: 1055-1062

Yeh T-C, Liu C-P, Cheng W-H, Chen B-R, Lu P-J, Cheng P-W, Ho W-Y, Sun G-C, Liou J-C, Tseng C-J (2014). Caffeine intake improves fructose-induced hypertension and insulin resistance by enhancing central insulin signaling. Hypertension 63: 535-541

Šap?anin A, Uzunovi? A, Jancan G, Pehli? E (2013). Determination of caffeine, theophylline, and theobromine content in energy drinks from Bosnian markets. Balkan Journal of Health Science 1: 35-38

Ogah CO, Obebe OT (2012). Caffeine Content of Cocoa and Coffee Beverages in Lagos, Nigeria. Journal of Innovative Research in Engineering and Sciences. 3(1): 404-411

Tarka MS, Hurst WJ (1998). Introduction to the Chemistry isolation, and biosynthesis of methylxanthines. In Caffeine; Spiller, GA Eds. CRC

Press: Boca Raton, 9-16.

Bispo MS, Veloso MCC, Pinheiro HLC, Oliveira RFSD, Reis JON, Andrade JBD (2002). Simultaneous determination of caffeine, theobromine, and theophylline by high-performance liquid chromatography. Journal of Chromatography Science 40: 45-48.

Belay A, Ture K, Redi M, Asfaw A (2008).Measurement of caffeine in coffee beans with UV/vis spectrometer. Food Chemistry. 108: 310-315.

He Q, Lv Y, Zhou L, Shi B (2010). Simultaneous determination of caffeine and catechins in tea extracts by HPLC. Journal of Liquid Chromatography and Related Techniques 33: 491-498.

Nehlig A (1999). Are we dependent upon coffee and caffeine? A review on human and animal data.Neuroscience Biobehavioral Reviews 23: 563-76.

Smith A (2002. Effects of caffeine on human behaviour. Food and Chemical Toxicology 40: 1243-1255

Ogawa N, Ueki H (2007). Clinical importance of caffeine dependence and abuse. Psychiatry and Clinical Neurosciences 61: 263-268

Laska EM, Sunshine A, Mueller F, Elvers WB, Siegel C, Rubin A (1984). Caffeine as an analgesic adjuvant. Journal of the American Medical Association 251(13): 1711?1718.

Sawynok J, Yaksh TL (1993). Caffeine as an analgesic adjuvant: A review of pharmacology and mechanisms of action. Pharmacological Reviews 45(1): 43?85.

Krymchantowski AV (2003). Overuse of symptomatic medications among chronic (transformed) migraine patients: profile of drug

consumption. Arquivos de Neuro-Psiquiatria 61: 43-47.

Diener HC, Pfaffenrath V, Pageler L, Peil H, Aicher B (2005). The fixed combination of acetylsalicylic acid, paracetamol and caffeine is more effective than single substances and dual combination for the treatment of headache: a multicentre, randomized, double-blind, single-dose, placebo-controlled parallel group study. Cephalalgia 25: 776-787.

Renner B, Clerke G, Grattan T, Beisel A, Mueller C, Werner U (2007). Caffeine accelerates absorption and enhances the analgesic effect of acetaminophen. Journal of Clinical Pharmacology 47: 715-726.

Parvathy S, Luiz A, Varkey JT (2014). Chemical Analysis of Caffeine Content in Tea and Coffee Samples. Asian Journal of Science and Applied Technology 3(1): 1-4

ICH (Q2B) (1996). Note for Guidance on Validation of analytical Procedures: Methodology. Geneva, Switzerland: IFPMA, International Conference on Harmonization

US Food and Drug Administration (FDA) (2006). Food Additives Status List, Food and Drug Administration. Retrieved form: http://www.cfsan.fda.gov/dms/opa-appa.html. classification of caffeine consumption. Assessed on 12 July 2019

Aroyeun SO, Shittu TR, Yahaya AT, Sowunmi FA, Odumbaku LA, Okelana FA, Akoroda MO (2013). Green tea processing in Nigeria and its economic implications. Global Advanced Research Journal of Management and Business Studies 2(1): 50-55.

Clifford MN, Ramirez-Martinez JR (1990). Chlorogenic acids and purine alkaloids contents of mate (Ilex paraguariensis) leaf and beverage. Food Chemistry 35: 13-21

Pradeep S, Rameshaiah GN, Ashoka H (2015). Caffeine extraction and characterization. International Journal of Current Research and

Review 7(9): 16-19

Nyirahabimana F, Uwimana P (2017). QuantitativeAnalysis of Caffeine Content from Different Tea Growing Regions of Rwanda. International Journal of Food Science and Biotechnology 2(2): 51-55.

Shao J, Zhang Y (2019). Determination of caffeine content in tea beverages IOP Conf. Ser.: Earth and Environmental Science 330: 042056

British Pharmacopoeia. 1993. Vol. I, 95.

Barone JJ, Roberts HR (1996). Caffeine consumption. Food and Chemical Toxicology 34: 119-129.

Nawrot P, Jordan S, Eastwood J, Rotstein J, Hugenholtz A, Feeley M (2003). Effects of caffeine on human health. Food Additives and Contaminants 20: 1-30.

Seifert SM, Schaechter JL, Hershorin ER, Lipshultz SE (2011). Health effects of energy drinks on children, adolescents, and young adults. Pediatrics 127: 511-528.

Benjamin LT, Rogers AM, Rosenbaum A (1991). CocaCola, Caffeine, and Mental Deficiency: Harry Hollingworth and the Chattanooga Trial of 1991. Nigeria Journal of Tree Crop Research 27: 42-45.

McGuire S (2014). Institute of Medicine. Caffeine in food and dietary Supplements: Examining safety: Workshop summary. Washington, DC: National Academies Press. Advances in Nutrition 5(5): 585-586

Sachse C, Brockmoller J, Bauer S, Roots I (1999). Functional significance of a C->A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine. British Journal of Clinical Pharmacology 47: 445-449.

Miles-Chan JL, Charriere N, Grasser EK, Montani JP, Dulloo AG (2015). The blood pressure-elevating effect of red bull energy drink is mimicked by caffeine but through different hemodynamic pathways. Plant Physiology Reports 3:e12290.

Similar Articles

You may also start an advanced similarity search for this article.